Heartland Group (HGH) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
15 Jun, 2026Executive summary
Reported NPAT for FY2024 was $74.5 million, down 22.2% year-over-year, with underlying NPAT at $102.7 million, 4.9% below guidance, mainly due to elevated provisions and one-off items.
Receivables grew 6.4% to $7.2 billion, with strong expansion in reverse mortgages in NZ (up 20.2%) and Australia (up 19.7%).
Strategic milestones included the acquisition and integration of Challenger Bank (now Heartland Bank Australia), a $210 million equity raise, and a core banking system upgrade in New Zealand.
FY2024 results were impacted by deteriorating economic conditions in late FY2024, leading to increased provisions, especially in Asset Finance, Motor Finance, and Rural portfolios.
Financial highlights
Net interest income was $277.6 million, down 1.5% year-over-year, with reported NIM at 3.39% (down 58 bps) and underlying NIM at 3.64% (down 36 bps).
Operating expenses rose to $139.4 million, with underlying OPEX down $1.3 million but higher IT and personnel costs; CTI ratio was 48.0% (reported) and 41.9% (underlying).
Impairment expense nearly doubled to $46.4 million, with total provisioning up $22 million and underlying impairment expense ratio at 0.44%.
Final dividend of 3.0 cps declared, with a 55% payout of underlying NPAT and an 8.7% yield.
Outlook and guidance
Long-term ambitions target underlying NPAT above $200 million, NIM above 4%, CTI ratio below 35%, and ROE of 12-14% by FY2028.
NIM expected to expand above 4% in NZ and above 3.4% in Australia by Q3 FY25, with CTI ratio projected to rise short-term but targeted to fall below 35% by FY28.
No formal FY2025 NPAT guidance due to ongoing volatility; payout ratio for FY25 expected at least 50%.
Integration of Heartland Bank Australia and digitalisation initiatives expected to drive future growth.
Latest events from Heartland Group
- FY2026 rebound underpins specialist growth, efficiency and the proposed TSB merger.HGH
AGM 2026 - Reverse Mortgage growth and improving asset quality supported 1Q earnings and FY targets.HGH
Q1 2027 TU - Merger approved to form a NZD 18.3B nationwide bank with cost synergies and growth focus.HGH
Scheme meeting 2026 - NPAT nearly doubled, asset quality improved, and a major merger is planned for FY27.HGH
H2 2026 - $620M merger forms NZ's seventh largest bank, targeting $34M synergies and EPS growth by 2026.HGH
M&A announcement - Impairment expenses surged amid rising arrears and defaults, with tough conditions expected to continue.HGH
Investor presentation - NPAT surged to $48.8m, with NIM and asset quality gains, and FY2026 guidance reaffirmed.HGH
H1 2026 - FY2025 underlying NPAT met guidance; FY2026 targets $85m+ NPAT and 7%+ ROE.HGH
H2 2025 - Profit dropped on higher impairments, but reverse mortgage growth and NIM expansion continue.HGH
H1 2025